Central Drugs Laboratory (CDL)

Central Drugs Laboratory (CDL)

The Central- Drugs laboratory is headed by the Director with its headquarters at Kolkatta. It is the Statutory Analytical Laboratory for drugs and cosmetics under DCA whose decision with regards to analysis is final in the court of law. The CDL is charged with the following responsibilities.

1. It takes up the analysis of samples of drugs and cosmetics sent by custom collectors and different courts.

2. As directed by the Central Government, it advises the Central Government and the State Governments and Union Territories on the matters pertaining to the analysis of drugs and cosmetics and also takes up analytical work of specific nature for samples sent by Central Government and State Governments.

3. It may take up the samples for analysis on payment of necessary fee for private parties, consumer organization, etc.

4. It is engaged in the research for the development of newer techniques of analysis of drugs and cosmetics.

For the analysis of following items, the Director of concerned laboratory as indicated, has all the powers of the Director of CDL under the provisions of the Act.

1. Director, Central Research Institute (CRI), Kasauli, H.P: for biological preparations such as vaccines, sera, toxins, toxoids, etc., and also bacteriophages, surgical sutures and ligatures.

2. Director, Indian Venterinary Research Institute (IVRI), Izzatnagar, U.P: for all biological products and other veterinary products meant for animals.

3. Director, Central Indian Pharmacopoeia Laboratory (CIPL) Ghaziabad, U.P: for all homoeopathic medicines and condoms.

4. Director, National Institute of Communicable Diseases:- Oral Polio Vaccine

The sample for analysis is required to be sent in sealed cover by registered post addressed to Director of the concerned laboratory. Alongwith this a memorandum filled in by the person sending the sample for analysis in accordance with the procedure laid down should be accompanied separately in the same registered post. Another copy of this memorandum is required to be sent separately with the impression of the seal by registered post to the Director. The registered post of sample and memorandum is received by the officer deputed on behalf of Director or Director himself. The impression of the seal in both the cases is compared and its genuinity is confirmed and only then, the seal is opened. The sample is required to be kept under the custody of the Director or the officer identified by him until the analysis is over and thereafter, for a period of one year. On completion of the analysis, the protocol followed for analysis, analytical results and other relevant information are sent by registered post to the concerned party. Depending upon the urgency of the matter, priority for analysis is fixed. The decision given by CDL regarding analysis is final and not challengable in the court of law.

Wings of DCA

1. Advisory Wing

(i) Drugs Technical Advisory Board and

(ii) Drugs Consultative Committee

2. Analytical Wing

(i) Central Drugs Laboratory

(ii) Government Analysts

(iii) Drug Testing Laboratories of the States

3. Administrative Wing

(i) Drugs Controller General oflndia

(ii) Drugs Control and Licensing Authorities of States

(iii) Drug Inspectors of Central and State Governments.